Gastrin-17

Gastrin-17

Gastrin-17 Molekülinformation

Molecule Name
Gastrin 17
Molekülalias
gastrin-17,gastrin 17,gastrin
Drug Development Progress
Anzahl der klinischen Arzneimittel1
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 2 Clinical
Target-Alias
Gastrin component II,Gastrin component III,GAS,G52,G34,G14,G17,G6,GAST,Gastrin component I,Gastrin-34,Gastrin-17,Gastrin,Preprogastrin
Molekülhintergrund
Gastrin is a peptide hormone that stimulates secretion of gastric acid (HCl) by the parietal cells of the stomach and aids in gastric motility. It is released by G cells in the pyloric antrum of the stomach, duodenum, and the pancreas. Gastrin binds to cholecystokinin B receptors to stimulate the release of histamines in enterochromaffin-like cells, and it induces the insertion of K+/H+ ATPase pumps into the apical membrane of parietal cells (which in turn increases H+ release into the stomach cavity). Its release is stimulated by peptides in the lumen of the stomach.

Gastrin-17 Produktliste

Species
  • Human(1)
Tag
  • Fc Tag & Avi Tag(1)
Host
  • HEK293(1)
Conjugate
  • Biotin-labeled(1)
Grade
  • RUO(1)
Low Endotoxin
  • No(1)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
Gastrin-17
Avitag
GA7-H82F4
Biotinylated Human Gastrin-17 Protein, Fc,Avitag™ (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

25ug
You Have Viewed 1-1 Of 1 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
Polyclonal antibody stimulator (Cancer Advances)G-17DTPhase 2 ClinicalAphton Corp
Colorectal Neoplasms; Diabetes Mellitus, Type 1; Esophageal Neoplasms; Jaundice; Pancreatic Neoplasms; Stomach Neoplasms
Details
Customer Reviews